Kleiner Perkins Caufield & Byers will invest $15 million of venture capital into Jinsite Science and Technology (Nanjing) Co Ltd, a CRO that is the China subsidiary of a US-based CRO, GenScript Corporation. Founded in 2004, Jinsite offers outsourced biological and pharmaceutical research. Like its parent GenScript, the company says it is a one-stop shop for all outsourcing tasks, from gene discovery to target identification and validation. More details...